Selank 10mg Anxiolytic Heptapeptide | Cognitive & Stress Adaptation Research Peptide
Selank 10mg Anxiolytic Heptapeptide | Cognitive & Stress Adaptation Research Peptide
Selank 10mg Anxiolytic Heptapeptide | Cognitive & Stress Adaptation Research Peptide
Overview Selank is a synthetic heptapeptide developed as a stabilised analogue of the endogenous immunomodulatory peptide tuftsin, with an additional Pro-Gly-Pro tripeptide extension that confers enhanced enzymatic stability. The 10mg presentation is engineered for advanced research into anxiolytic signalling, cognitive performance under stress, and immunomodulatory pathways within the central nervous system.
Mechanism of Interest Selank is recognised in the research literature for its multi-system activity bridging the GABAergic, serotonergic, and immunomodulatory pathways. Research has explored its influence on the expression of brain-derived neurotrophic factor (BDNF), enkephalin metabolism, monoamine balance, and cytokine signalling — distinguishing it from classical anxiolytic-class compounds, which typically act through narrower receptor mechanisms. Its peptidic nature and stabilised structure make it a uniquely positioned tool in research models exploring stress, cognition, and neuroimmune interaction.
Product Specifications
- Product Name: Selank 10mg
- Catalogue Reference: SEL10-024
- Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
- Molecular Formula: C₃₃H₅₇N₁₁O₉
- Molecular Weight: 751.88 g/mol
- Purity: ≥98% (HPLC verified)
- Presentation: Lyophilised solid
- Storage: -20°C
Research Applications Selank is utilised across neuroscience, behavioural research, and neuroimmunology — particularly in studies investigating anxiety and stress-response models, cognitive performance under load, BDNF expression, enkephalinase inhibition, immune modulation, and serotonergic / GABAergic signalling. Its broad activity profile makes it a refined research tool where stress adaptation, cognition, and immune-CNS crosstalk intersect.
Comparative Research Context Selank is frequently studied alongside Semax in comparative nootropic and neurorestorative research models. Where Semax is typically explored for its emphasis on attentional performance, neurotrophic expression, and dopaminergic signalling, Selank is differentiated by its anxiolytic and immunomodulatory profile — offering complementary research utility within the broader Russian-developed regulatory peptide class.
Quality & Handling Synthesised under controlled laboratory conditions and supplied as a lyophilised solid for maximum stability. Reconstitution with appropriate bacteriostatic solution is required prior to use in any research model. Every batch is subjected to rigorous quality control to ensure ≥98% purity, identity, and reproducibility.
Compliance Statement All Asclepius peptide products are supplied strictly for laboratory research purposes. They are not intended for human consumption, diagnosis, treatment, or therapeutic use. Enquiries relating to human application cannot be supported.
Order with Confidence Asclepius peptides are sourced, tested, and dispatched to a clinical standard — built for researchers and practitioners who refuse to compromise on integrity, purity, or precision.
For technical specifications, certificates of analysis, or research support, our team is available to assist.